Production & Manufacturing
OTC

OTC News

View news from other Pharmaceutical sectors:
121-135 of 1693 results
Pfizer to expand caltrate and centrum production in China with new $95m production plant
By PBR Staff Writer
Pfizer has started construction of a new $95m production facility in Suzhou, China, to expand its production of Caltrate dietary supplements and Centrum multivitamins in the region.
Production & Manufacturing > OTC > News
New bill unveiled to make birth control pills available without prescription in US
By PBR Staff Writer
A new bill has been unveiled in the US to make birth control pills approved by the Food and Drug Administration, available without a prescription, to help expand women’s access to affordable contraceptives.
Production & Manufacturing > OTC > News
Convergence Point Media opens eHealthStore for ready-to-buy health consumers
By PBR Staff Writer
Convergence Point Media (CPM) has launched a mobile health shopper network, eHealthStore, to deliver convenience of online shopping with the ability to enable ready-to-buy health consumers to instantly find their product.
Production & Manufacturing > OTC > News
Glukos delivers first production batch of its fruit punch tablets
By PBR Staff Writer
US-based natural performance energy foods brand, The Glukos Company, has handed over the first production batch of its fruit punch tablets to US midfielder, Tobin Heath.
Production & Manufacturing > OTC > News
Oculus receives FDA clearance for novel atopic dermatitis dermatology product
Oculus Innovative Sciences, a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Alevicyn SG Antipruritic Spray Gel with both prescription and over-the-counter indications.
Production & Manufacturing > OTC > News
FDA approves Actavis and Perrigo's application for generic chest congestion tablets
By PBR Staff Writer
Actavis and Perrigo have secured approval from the US Food and Drug Administration for their abbreviated new drug application (ANDA) for guaifenesin/pseudoephedrine tablets.
Production & Manufacturing > OTC > News
Perrigo to buy OTC drugs portfolio of GlaxoSmithKline
By PBR Staff Writer
Irish pharmaceutical company Perrigo is buying a portfolio of OTC brands in the uropean Economic Area (EEA), Brazil, and Australia, from GlaxoSmithKline (GSK).
Production & Manufacturing > OTC > News
Actavis completes Auden Mckenzie acquisition for £306m
By PBR Staff Writer
Irish over-the-counter (OTC) firm Actavis has completed the acquisition of Auden Mckenzie Holdings, a company focused on the development niche generic medicines and proprietary brands in the UK.
Production & Manufacturing > OTC > News
Moberg Pharma gets European Patent for Kerasal Nail
Moberg Pharma has announced that the European Patent Office has issued patent no. 2,777,689 for an improved formulation of Moberg Pharma’s market-leading OTC product for the treatment of fungal nails, sold in the U.S. under the Kerasal Nail brand. The patent expires in 2034.
Production & Manufacturing > OTC > News
FDA approves Actavis' Viberzi to treat irritable bowel syndrome with diarrhea in adults
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Irish OTC firm Actavis' Viberzi (eluxadoline) as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D), a multifactorial disorder.
Production & Manufacturing > OTC > News
PharmaCenter to begin marketing EastGate's nutraceutical products
By PBR Staff Writer
US company EastGate Biotech has selected Hungary-based PharmaCenter to market E-drops, one of the company's nutraceutical products in Slovakia and Czech Republic.
Production & Manufacturing > OTC > News
Actavis confirms appeals Court Ruling requiring continued distribution of NAMENDA IR
Actavis confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014 preliminary injunction requiring the Company to continue distribution of NAMENDA (memantine HCl) immediate-release tablets.
Production & Manufacturing > OTC > News
Moberg Pharma partner Menarini Asia-Pacific introduces Kerasal Nail in china
Moberg Pharma has announced that its partner, Menarini Asia-Pacific, has initiated the launch of Kerasal Nail in China. TV commercials and other advertising started this week in certain parts of southern China.
Production & Manufacturing > OTC > News
Sunovion reports positive results for Latuda in first placebo-controlled trial in MDD patients
Sunovion Pharmaceuticals (Sunovion) announced results from the first placebo-controlled study in adults with major depressive disorder (MDD) who presented with a limited number of associated manic symptoms (mixed features).
Production & Manufacturing > OTC > News
Inergetics, Muscle Maker Grill introduce new booster supplements product line
Inergetics, a world-class developer of nutritional and consumer health products, announced the launch of a new product line of booster supplements at Muscle Maker Grill locations across the US.
Production & Manufacturing > OTC > News
121-135 of 1693 results